Do you have Stage III or Stage IV Non-Small Cell Lung Cancer? Do you have a KRAS G12C mutation or are you interested in testing for this? If so, you may be able to participate in a study to see if adding a new medicine is more effective at controlling your cancer than the usual treatments.

Have you ever been concerned about your eating? We're inviting adults in the U.S. who have ever had anorexia nervosa, atypical anorexia nervosa, bulimia nervosa, binge-eating disorder, or avoidant/restrictive food intake disorder (ARFID) at any point in their life to take our survey. No official medical diagnosis is required. Common signs of different eating disorders may include: restricting the amount or type of food you eat or eating excessive amounts of food in one sitting. Some other possible signs are making yourself throw up, using diet pills or laxatives, excessively exercising, or fasting to alter your weight. Only with your help can we the causes and potential cures for these disorders. Eligible participants who complete Core Questionnaires and return their saliva sample will receive a $30 gift card.

Do you have bladder cancer and have had your bladder removed? If so, you may be able to take part in a research study to determine if patients need additional treatment called immunotherapy to prevent cancer from coming back.

Have you been diagnosed with pancreatic adenocarcinoma? If so, you may be a good fit to help us learn if combination treatment with specific drugs may stimulate the body's immune system against cancer cells.

Have you ever noticed yourself repeatedly thinking or doing specific things? Have you experienced symptoms of OCD now or in the past (even if you did not seek treatment)? Do you identify as Black? If you have (or think you might have) OCD, you may be able to participate in a study to learn more about OCD and new methods for prevention and treatment. Participants will receive $50.

Have you been diagnosed with Multiple Myeloma? Have you received idecabtagene vicleucel (ide-cel (Abecma)) CAR-T treatment? If so, you may be able to take part in a research study looking at for how long a new drug called iberdomide will keep Multiple Myeloma under control (in remission).

Efgartigimod has been approved by the U.S. FDA (Food and Drug Administration) as a treatment for adult patients with gMG in whom AChR-Ab's are present. However, it was not approved it for the form of gMG that is AChR Ab seronegative (antibodies not present). and therefore this study is now testing how efragtigimod works in patients without any antibodies,

Do you have Hidradenitis Suppurativa (HS)? You may be eligible to participate in a research study assessing the effect of an investigational product in HS and its impact on quality of life. If eligible, and you decide to participate, you will receive the study drug study related medical evaluation and compensation for completed visits.

Have you been diagnosed with s Cutaneous (skin) Lymphoma? If so this could be a good study for you to paticipate in. One of the primary goals of the USCLC is to establish a registry of patients with cutaneous lymphoma in the United States. Such a registry would collect information such as the specific cutaneous lymphoma diagnosis, stage of disease, treatments used, and response to treatments. This information will collected on an online Institutional Review Board (IRB)-approved database/registry of patients from all sites. We hope that this will allow providers to better understand this rare disease by looking at data from many patients. We hope ultimately will include all the patients with cutaneous lymphoma across the United States

If you have NMOSD, you are between the ages of 18 and 60, and you use a smart phone, you may be able to participate in a clinical trial testing a new self-assessment tool app. Compensation provided.